This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genmab A+s. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Jeroen Lammerts Van Bueren: Innovator in Cancer Treatment
Introduction
Jeroen Lammerts Van Bueren is a notable inventor based in Harderwijk, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic methods.
Latest Patents
Jeroen holds a patent for "Methods and antibodies for treating cancer." This invention relates to novel methods for the treatment of tumors, which involve the administration of a bispecific antibody or a combination of two or more non-cross-blocking antibodies that recognize the same target antigen or antigenic complex. In particular, the invention focuses on a method for inducing complement-mediated cell killing in the treatment of a tumor. This method comprises the combined administration, to a human being in need thereof, of a first antibody and a second antibody.
Career Highlights
Jeroen is currently associated with Genmab A/S, a leading biotechnology company specializing in the development of differentiated antibody therapeutics for the treatment of cancer. His work at Genmab has been pivotal in advancing cancer therapies and improving patient outcomes.
Collaborations
Throughout his career, Jeroen has collaborated with esteemed colleagues, including Jan Van De Winkel and Paul Parren. These collaborations have fostered innovation and have been instrumental in the development of groundbreaking cancer treatments.
Conclusion
Jeroen Lammerts Van Bueren is a distinguished inventor whose work in cancer treatment exemplifies the impact of innovative research in medicine. His contributions continue to pave the way for advancements in therapeutic strategies against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
